Log in to search using one of your social media accounts:


HDL-Raising Drugs: No Value in the Statin Era?HDL-Raising Drugs: No Value in the Statin Era?

In the era of widespread statin use, investigators say studies testing fibrates, niacin, and CETP inhibitors do not support raising HDL pharmacologically to reduce clinical outcomes. Heartwire
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news

Related Links:

More News: Cardiology | Cholesterol | Heart | Niacin | Niaspan | Statin Therapy | Study